Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study

Authors

Institutions

Publication Details

Journal
Allergy Asthma and Clinical Immunology
Published
2026-01-21
DOI
https://doi.org/10.1186/s13223-025-01007-9
Primary Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study

Paul Keith, Hugo Chapdelaine, Ahmed El-Zoeiby, M. Dawn Goodyear et al.
Allergy Asthma and Clinical Immunology
Coagulation, Bradykinin, Polyphosphates, and Angioedema
article

Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study

Paul Keith, Hugo Chapdelaine, Ahmed El-Zoeiby, M. Dawn Goodyear, Stephen D. Betschel, Natalie Khutoryansky, Daniel N. Castaner, Remi Gagnon
article en

Abstract

No abstract available for this paper.
Allergy Asthma and Clinical ImmunologyVol. 22(1)
University of Calgary (CA), University of Toronto (CA), Yale University (US), Takeda (United States) (US), Centre Hospitalier de l’Université de Montréal (CA), Montreal Clinical Research Institute (CA), Takeda (Canada) (CA), McMaster University (CA)
Openalex Percentile: Top 83%
Coagulation, Bradykinin, Polyphosphates, and Angioedema
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.